Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Synovis takes Veritas biomaterial to Canada:

This article was originally published in Clinica

Executive Summary

Synovis Surgical Innovations has gained approval in Canada to market its implantable remodellable biomaterial for use in three applications - pelvic floor reconstruction, pelvic organ prolapse repair and as a sling for the treatment of stress urinary incontinence. The Veritas collagen matrix product is currently being assessed in studies at five US centres. Clinical data from the studies, so far, indicate that the implant is efficacious in the approved applications, with no infections, rejections or erosion of the implanted tissue, said the St Paul, Minnesota firm, a division of Synovis Life Technologies. The Veritas implant is already cleared in the US for the same applications.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts